Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-17 7:15 pm Purchase | 2026-06-10 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Coastlands Capital LP | 410,530 9.990% | 143,991 (+54.02%) | Filing History |
| 2026-06-17 5:18 pm Purchase | 2026-06-05 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Domicilium Capital Partners LLC | 854,973 19.990% | 831,495 (+3541.59%) | Filing History |
| 2026-06-16 7:10 pm Purchase | 2026-06-09 | 13G | ELOXX PHARMACEUTICALS INC ELOX | EcoR1 Capital, LLC | 403,586 9.900% | 403,586 (New Position) | Filing History |
| 2026-06-16 6:04 pm Purchase | 2026-06-09 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Stonepine Capital Management, LLC | 403,228 9.900% | 403,228 (New Position) | Filing History |
| 2026-06-15 6:02 pm Purchase | 2026-06-09 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Invus Public Equities, L.P. | 403,586 9.990% | 403,586 (New Position) | Filing History |
| 2026-06-05 10:47 am Sale | 2026-05-27 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Domicilium Capital Partners LLC | 23,478 4.900% | -1,383,660 (-98.33%) | Filing History |
| 2026-05-29 9:55 pm Sale | 2026-05-27 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Coastlands Capital LP | 24,231 4.990% | -89,405 (-78.68%) | Filing History |
| 2026-05-04 6:18 pm Purchase | 2026-04-27 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Domicilium Capital Partners LLC | 127,922 18.600% | 127,922 (New Position) | Filing History |
| 2026-05-01 9:55 pm Purchase | 2026-04-27 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Coastlands Capital LP | 113,636 16.510% | 113,636 (New Position) | Filing History |
| 2024-08-20 8:13 pm Purchase | 2024-08-20 | 13D | ELOXX PHARMACEUTICALS INC ELOX | Advent Life Sciences LLP | 11,361 3.980% | 5,606 (+97.41%) | Filing History |
| 2023-02-13 4:52 pm Sale | 2022-12-31 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Roche Finance Ltd | 172 0.100% | -11,189 (-98.49%) | Filing History |
| 2022-02-14 06:18 am Purchase | 2021-12-31 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Roche Finance Ltd | 11,361 5.800% | 5,606 (+97.41%) | Filing History |
| 2022-02-03 4:16 pm Unchanged | 3021-12-31 | 13D | ELOXX PHARMACEUTICALS INC ELOX | LSP V Cooperatieve U.A. | 6,713 3.400% | 0 (Unchanged) | Filing History |